Radar › Companies › Genomics · South Holland
Radar · Genomics in South Holland

Best Genomics Companies in South Holland, Netherlands

The 30 best Genomics companies in South Holland, Netherlands in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Bluebee.

30companies tracked
$46.2Mdisclosed funding
0unicorns
16have raised
FLIAR INTELLIGENCE · GENOMICS × SOUTH HOLLAND

Our analysis of 50 Genomics companies

$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.

50companies analysed
84%cloud-native stacks
2025funding peak (by rounds)
2unicorns
2016median founding year
51kcombined LinkedIn audience
61%of audience held by top 3
3companies hiring publicly (12 mo)

Ranked: Best Genomics companies in South Holland

#CompanyDisclosed fundingLast roundEmployeesFounderTech stackPatents & IP focusRecent signals
1Bluebee
Provider of solutions for genomics data analysis
$13M127 mo ago31————
2Amarna Therapeutics
Developer of immune-modulating gene therapies for rare and prevalent autoimmune diseases and genetic diseases
$11M85 mo ago30Marjanne Messie
CFO
CMS Made SimplePleskPHP+155 patents
Patents concentrated in chemistry & materials
—
3ProteoNic
Provider of products and services for improving recombinant protein production levels
$8M181 mo ago20Frank Pieper
CEO
WordPressMySQLPHP+23——
4Facio Therapies
Provider of small molecule therapeutics for Facioscapulohumeral Dystrophy
$3M133 mo ago7David Dasberg
CEO
———
5Genewity
Biotech company focused on commercializing potentially groundbreaking therapies in the field of cell and gene…
$3M44 mo ago—Arno Bisschop
Co-Founder & CEO
—2 patents
Artificial thymus production for immune cell therapy and regenerative immunology
—
6SkylineDX
Provider of gene expression profiling tests for personalized medicine
$2M59 mo ago61Dharminder Chahal
CEO
WordPressMySQLPHP+1927 patents
Predictive gene expression signatures for melanoma prognosis and therapy response
—
7TherageniX
Developer of non-viral delivery system for tissue regeneration
$1M38 mo ago—Anandkumar Nandakumar
Co-Founder & CEO
———
8GenomeScan
Provider of next-generation genome sequencing and testing
$1M48 mo ago38Peter Belt
CEO
WordPressMySQLPHP+28——
9BaseClear
Contract service laboratory with a focus on DNA technology, genomics and synthetic biology.
$1M87 mo ago96—WordPress Block EditorCart FunctionalityWordPress+27——
1020Med Therapeutics
Develops RNA-based therapeutics and vaccines for drug delivery
$736K42 mo ago13Michiel Lodder
CEO
—15 patents
Polymer-functionalized nanocarriers for gene and drug delivery applications
—
11Amylon
Developer of RNA therapeutics for rare beta-amyloid related diseases
$348K108 mo ago2Daniel de Boer
Co-Founder
———
12Imuno Therapeutics
Developer of drug discovery and precision therapy platform for oncology
$340K60 mo ago5Jan Verhoef
Founder
———

Top 12 Genomics companies in South Holland

#1
Funding Raised · Leiden, South Holland · founded 2022
$3.1Mraised
▾

Biotech company focused on commercializing potentially groundbreaking therapies in the field of cell and gene therapies.

Funding rounds
  • Mar 2023Grant (prize money)$3.1M
Founders & team
Arno BisschopCo-Founder & CEOMax RenesCo-Founder
Investors
EIC Fund
#2
Funding Raised · The Hague, South Holland · founded 2022
$1.2Mraised
▾

Developer of non-viral delivery system for tissue regeneration. The company uses proprietary technology to deliver genes that can instruct the body to produce relevant proteins or factors that help in tissue regeneration.

Funding rounds
  • Sep 2023Grant (prize money)$1.2M
Founders & team
Anandkumar NandakumarCo-Founder & CEO
Investors
Ukri, NLC
#3
Series A · Leiden, South Holland · founded 2008 · 30 employees
$11Mraised
▾

Developer of immune-modulating gene therapies for rare and prevalent autoimmune diseases and genetic diseases. Its proprietary platform includes SVac which is a viral vector used for the delivery of gene, prophylactic and therapeutic vaccines targeting indications such as allergies, autoimmune diseases, genetic disorders, cancer, and infectious diseases. It can be used for the treatment of AMD, HIV, Hepatitis, multiple sclerosis, and breast cancer.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers — 6.3% of this cohort's audience
Funding rounds
  • Oct 2019Series A$11M
Founders & team
Marjanne MessieCFO
Investors
Rijksdienst voor Ondernemend Nederland, Flerie
Tech stack
Cms Made SimplePhpBootstrapNginxOwl CarouselModernizr
#4
Acquired · Delft, South Holland · founded 2011 · 31 employees
$13.3Mraised
▾

Bluebee provides solutions for genomics data analysis to enable personalized medicine. The company provides a cloud-based platform to researchers and clinical labs to enable large-scale analysis of genomic data. Their proprietary algorithms provides next-gen sequencing analytics for alignment, and mapping and variant calling.

Funding rounds
  • Mar 2016Series A$11.3M
  • May 2015Series A$1.9M
Investors
Buysse & Partners, TU Delft, Capricorn Partners, Korys, Quest for Growth, YES!Delft
Tech stack
Adobe Experience ManagerJavaBootstrapAmazon Web ServicesApache Http ServerOnetrust
#5
Funding Raised · Leiden, South Holland · founded 2002 · 38 employees
$1.2Mraised
▾

Provider of next-generation genome sequencing and testing. The company is focusing on NGS genetic testing and diagnostics, exome sequencing, targeted disease panels, and research and development on genetic testing. The company is involved in finding disease causes using Next Generation Sequencing.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 4k LinkedIn followers — 8.5% of this cohort's audience
Hiring: 1 hiring post in 12 mo (public) · hiring: Director Commercial Laboratory
Funding rounds
  • Nov 2022Grant (prize money)$270.8K
  • Jan 2020Grant (prize money)$312.9K
  • Oct 2019Grant (prize money)$305K
  • Jan 2017Grant (prize money)$336K
Founders & team
Peter BeltCEO
Investors
Europa
Tech stack
Amazon S3Amazon Web ServicesAnime.JsCloudflareCloudflare Bot ManagementCookiebot
#6
Series A · South Holland · founded 2011 · 13 employees
$735.8Kraised
▾

Develops RNA-based therapeutics and vaccines for drug delivery. Its non-viral delivery platform is based on bioresponsive polymers designed for the intracellular delivery of oligonucleotides. The 20Med Nanoparticles are applicable for the delivery of oligonucleotide-based therapeutics. Its nanogel drug delivery platform provides protection of fragile payloads during administration and circulation but allows for a rapid bioresponsive release of that payload as the particles enter the cytosol. The bioresponsive polymeric nanoparticles can be loaded with oligonucleotides ranging from large plasmid DNAs (>12Kb) to small antisense oligos.

Funding rounds
  • May 2023Series A—
  • Sep 2020Grant (prize money)$316.7K
  • Nov 2017Seed—
  • Jan 2017Grant (prize money)$419.1K
Founders & team
Michiel LodderCEO
Investors
Twente Technology Fund, Oost NL, Europa, Innovation Industries
#7
Seed · Rotterdam, South Holland · founded 2005 · 61 employees
$2.4Mraised
▾

Provider of gene expression profiling tests for personalized medicine. Its proprietary platform Profiler includes a fully secure data analysis system for transcriptomics. Its lead product MMProfiler enables risk stratification of multiple myeloma patients by analyzing expression data of 92 clinically validated genes. It also has another product AML Profiler for subtyping acute myeloid leukemia varieties that is on the market. The company is developing another diagnostic tool for APprofiler for detection of angina pectoris.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers — 12.2% of this cohort's audience
Funding rounds
  • Dec 2021Seed—
  • Jan 2020Grant (prize money)$280.5K
  • Nov 2016Grant (prize money)$2.1M
  • Oct 2016Grant (prize money)—
Founders & team
Dharminder ChahalCEO
Investors
European Innovation Council, Van Herk Groep, Europa, Novalis LifeSciences, EQT, Innovation Industries
Tech stack
CloudflareCloudflare Bot ManagementCloudflare Browser InsightsCookieyesCore-JsElementor
#8
Series A · Leiden, South Holland · founded 2007 · 20 employees
$8.1Mraised
▾

Provider of products and services for improving recombinant protein production levels. Its proprietary UNic technology is used to enhance the translation of messenger RNA (mRNA) by incorporating Translation enhancing elements in the expression vector, resulting in more protein per mRNA. This leads to significantly higher yields and greater manufacturing flexibility, with lower production costs. The company activities focus on industry-relevant fungal, yeast, plant, and mammalian expression hosts, for which it has developed platform-specific products and services. Services include molecular biology, vector construction, cell line, and production strain development.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers — 4.3% of this cohort's audience
Funding rounds
  • Sep 2011Series A$8.1M
Founders & team
Frank PieperCEO
Investors
fairbanksfund.com
Tech stack
CloudflareCloudflare Bot ManagementComplianzContact Form 7Core-JsElementor
#9
Series A · Leiden, South Holland · founded 2014 · 7 employees
$3.1Mraised
▾

Provider of small molecule therapeutics for Facioscapulohumeral Dystrophy. The disease is caused by the absence of repression of the DUX4 gene, causing accumulation of the unwanted DUX4 protein in the muscle cells leading to dystrophy. The company has developed a technology platform that enables high-throughput screening of compounds for their ability to repress the expression of DUX4 in primary cultures of muscle cells from FSHD patients.

Funding rounds
  • Oct 2015Series A$3.1M
Founders & team
David DasbergCEO
#10
Funding Raised · Leiden, South Holland · founded 1993 · 96 employees
$1.2Mraised
▾

BaseClear is a contract research laboratory offering a suite of tailored services for metagenomics, genome analysis, microbial identification and typing, protein engineering and synthetic biology. It is using Next Generation Sequencing (NGS) technologies such as Illumina HiSEQ, MiSEQ and PacBio RS II platforms for metagenomics, genome analysis related projects. It also offers a wide range of bioinformatics solutions with a focus on NGS data analysis. In addition, it also provides a range of services in synthetic biology such as synthetic DNA libraries, custom cloning and others.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 8k LinkedIn followers — 16.4% of this cohort's audience
Hiring: 3 hiring posts in 12 mo (public) · momentum +3 · hiring: QA Officer, Scientific (Digital) Marketing Manager
Funding rounds
  • Aug 2019Grant (prize money)$210.9K
  • Jan 2019Grant (prize money)$162.1K
  • Jan 2018Grant (prize money)$306.7K
  • Dec 2016Grant (prize money)$544.5K
Investors
Europa
Tech stack
Cart FunctionalityCloudflareCloudflare Bot ManagementCookie NoticeFont AwesomeGoogle Analytics
#11
Seed · Leiden, South Holland · founded 2023
$20Kraised
▾

Platform for gene editing applications and educational assistance in biological topics. It facilitates knowledge retrieval in biological domains, offering strategy prototyping for gene editing applications, and serving as an educational assistant for biological topics. The platform captures genetic and epigenetic information in a workflow to support the understanding of normal and disease biology. Its technology enables the phased reading of genetic and epigenetic data at a single-base resolution.

Funding rounds
  • 2024Seed$20K
Founders & team
Fabio BiginiCo-Founder & CEOBilly Der HelmCo-Founder
Investors
Techstars
#12
Seed · Leiden, South Holland · founded 2020 · 5 employees
$340.3Kraised
▾

Developer of drug discovery and precision therapy platform for oncology. The company has developed a proprietary technology platform to identify 3D models of neo-epitopes from the cell surface of a patient's tumor. This enables to the design of patient-specific immunotherapies.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers — 4.4% of this cohort's audience
Funding rounds
  • Nov 2021Seed$340.3K
Founders & team
Jan VerhoefFounder
Investors
UNIIQ, Libertatis Ergo Holding, InnovationQuarter

Funding & investor landscape

$46.2Mtotal disclosed funding
14companies funded
25disclosed rounds
0rounds last 90 days
Most active investors
Europa5 rounds
InnovationQuarter3 rounds
EQT2 rounds
Innovation Industries2 rounds
Libertatis Ergo Holding2 rounds
UNIIQ2 rounds
BioGeneration Ventures1 rounds
Broadfin Capital1 rounds
Buysse & Partners1 rounds
Capricorn Partners1 rounds

Notable founders

Arno Bisschop
Co-Founder & CEO · Genewity
Max Renes
Co-Founder · Genewity
Anandkumar Nandakumar
Co-Founder & CEO · TherageniX
Marjanne Messie
CFO · Amarna Therapeutics
Peter Belt
CEO · GenomeScan
Michiel Lodder
CEO · 20Med Therapeutics
Dharminder Chahal
CEO · SkylineDX
Frank Pieper
CEO · ProteoNic
David Dasberg
CEO · Facio Therapies
Fabio Bigini
Co-Founder & CEO · Biomod AI
Billy Der Helm
Co-Founder · Biomod AI
Jan Verhoef
Founder · Imuno Therapeutics
Prism market signals · Netherlands · country-scoped Prism corpus, 100,937 docs

Market landscape — 10 sub-themes by coverage

Share of Genomics coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

Common questions

How many Genomics companies are there in South Holland, Netherlands?
Radar tracks 30 indexable Genomics companies headquartered in South Holland, Netherlands that meet our profile-completeness bar.
What is the total funding raised by Genomics companies in South Holland, Netherlands?
The Genomics companies in South Holland, Netherlands on this list have raised a combined $46.2M in disclosed equity funding across 14 funded companies.
Which is the highest-funded Genomics company in South Holland, Netherlands?
Bluebee is the highest-funded Genomics company in South Holland, Netherlands, with $13.3M in disclosed equity funding.
How many Genomics companies in South Holland, Netherlands are funded?
14 of the 30 Genomics companies in South Holland, Netherlands on this list have disclosed at least one equity funding round.
How many Genomics unicorns are there in South Holland, Netherlands?
None of the Genomics companies in South Holland, Netherlands on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in South Holland, Netherlands Genomics companies?
The most active investors in South Holland, Netherlands Genomics companies on this list include Europa, InnovationQuarter, EQT, Innovation Industries, Libertatis Ergo Holding.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon